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Objective: The etiology of Condylar hyperplasia (CH) of human temporomandibular joint (TMJ) remains
largely unknown. Our previous study has demonstrated that enriched insulin-like growth factor-1(IGF-1)
was expressed in the proliferation and hypertrophic layers of CH cartilage. Accordingly, this study was
aimed to investigate whether IGF-1 regulates CH chondrocytes proliferation in condylar cartilage over-
growth and explore the molecular mechanism of IGF-1 involved in.
Methods: Chondrocytes were isolated from 6 CH and 3 normal cartilage (NC) specimens and cultured in
alginate beads or monolayer, treated with IGF-1 or speciﬁc inhibitors such as 7-[trans-3-[(azetidin-1-yl)-
methyl]cyclobutyl]-5-(3-benzyloxyphenyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine (NVP-AEW541), U0126,
and LY294002. Thereafter, cellular proliferation capacity was evaluated by Cell Viability Analyzer (alginate
beads culture) or 3-(4,5-dimethylthiazo(-2-yl)-2,5-diphenyltetrazolium bromide (MTT) (monolayer
culture). Gene expression levels of IGF-1, IGF-1 receptor (IGF-1R), collagen type II, type X and those genes
associatedwith proliferationwere evaluated by realtime PCR. Protein levels of IGF-1 and IGF-1R synthesized
by CH chondrocytes were accessed by enzyme-linked immunosorbent assay (ELISA) and western blotting.
Results: CH chondrocytes enhanced cellular proliferation capacity and expressed signiﬁcantly higher
levels of messenger RNA (mRNA) and protein expressions of IGF-1 and IGF-1R, as compared with NC
chondrocytes. Furthermore, enriched IGF-1 enhanced CH chondrocytes proliferation, up-regulated the
expressions of speciﬁc genes associated with cellular proliferation and elevated the gene expression of
collagen type II A1 (COL2A1). Besides, IGF-1-mediated CH chondrocytes proliferation mainly depended
on the mitogen-activated protein kinase (MAPK)eERK pathway.
Conclusions: IGF-1 promotes human TMJ cartilage overgrowth in the developing process of CH by
enhancing chondrocytes proliferation via MAPKeERK pathway.
 2012 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Condylar hyperplasia (CH) in human temporomandibular joint
(TMJ) is deﬁned as a postnatal and self-limited growth abnormality
which occurs unilaterally and leads to facial asymmetry and
occlusal disturbance1. It usually develops in the teens, early 20s and
sometimes after the opposite condyle has stopped growing with
equal frequency in males and females1e3. It is widely accepted that
an accelerated or prolonged growth after the end of general skeletal
growth of a condyle is the main cause of such deformity in human: X. Long, Wuhan University,
Maxillofacial Surgery, Luoyu
-87686216.
ong).
s Research Society International. PTMJ4. Single-photon emission computed tomography (SPECT) bone
scintigraphy, the golden standard for the clinical diagnosis of CH, is
frequently used to the growth activity of the TMJ condyle. The
typical histological features of CH include the presence of an
uninterrupted layer of undifferentiated germinating mesenchymal
cells, hypertrophic cartilage, and islands of chondrocytes in the
subchondral trabecular bone2,5.
Insulin-like growth factors 1 (IGF-1) exerts important roles in
human growth and development6. IGF-1 regulates the metabolism
like increasing lipid, glycogen, and protein synthesis. IGF-1 has
effects on muscle and bone by stimulating proliferation and
promoting differentiation of myoblastic or osteoblastic tissues6. In
the growth plate of longitudinal bone, IGF-1 is a key growth factor
exerting its actions to stimulate proliferation and differentiation of
chondrocytes by endocrine and paracrine/autocrine mechanisms7.
The IGF-1 receptor (IGF-1R), acting as a docking protein for theublished by Elsevier Ltd. All rights reserved.
Table II
NC chondrocytes samples analysis
Case Gender Age (years) Affected side
1 m 14 Right
2 f 20 Left
3 f 23 Left
Y. Chen et al. / Osteoarthritis and Cartilage 20 (2012) 279e287280downstream signaling transduction, is overexpressed in many
tumors and have vastly different functions like mediates cancer
cells proliferation, motility and apoptosis protection8,9.
Concerning the unique role of the IGF-1 in somatic development,
recent studies have started focusing on the relationship between
IGF-1 and TMJ condyle cartilage growth. IGF-1 regulated adaptive
remodeling of mandibular condylar cartilage by an onset or
enhanced proliferation of chondrocytes10. Elevated expressions of
IGF-1 and IGF-1R were found in cartilage and bone of active CH11.
Also, our previous study showed that strong immunostainingof IGF-
1 was in the proliferative chondrocyte layer and the hypertrophic
chondrocyte layer12, indicating that the abnormality of the cartilage
growth in CH is probably attributed to IGF-1 overexpression.
The aim of this study was to investigate whether IGF-1 regulates
CH chondrocytes proliferation, thereby resulting in condylar
cartilage overgrowth. The molecular mechanism of IGF-1 medi-
cated CH chondrocytes proliferation was also investigated.
Materials and methods
Samples and chondrocyte culture
The condyle cartilage samples of CH were obtained from six
patients (Table I) following surgeries of condylectomy in the sto-
matology hospital of Wuhan university. All patients were diag-
nosed by SPECT and conﬁrmed growth activity in the affected
lateral condyle13. Normal cartilage (NC) samples as the control
group were harvested from condyle fractured patients (Table II),
and the specimens were conﬁrmed as NC tissues by histological
examination. The experimental protocol was approved by the
Human Research Ethics Committee, School & Hospital of Stoma-
tology, Wuhan University and written consent was obtained from
all patients included in this study.
Chondrocytes were isolated by collagenase B (Roche, France)
digestion of cartilage, as described previously14, and grown in
DMEM (Hyclone, USA) supplemented with 10% fetal bovine serum
(FBS) at 37C, in a humidiﬁed atmosphere containing 5% CO2 in air.
After chondrocytes reached 80e90% conﬂuence, they were encap-
sulated in alginate beads as described previously15 at a concentra-
tion of 2 106 cells/ml (an average number of 8.8 104 cells/bead).
Then alginate beads were transferred into 24-well plates at
a density of two beads/well in 1 ml of medium at 37C in a humid-
iﬁed atmosphere of 5% CO2.Mediumwas preparedwith DMEM/F12,
10% FBS, 100 units/ml penicillin, and 100 mg/ml streptomycin and
changed every 2 days16.
Cellular proliferation assays
To determine whether IGF-1 enhances CH chondrocytes prolif-
eration, encapsulated beads were randomly divided into the
following four groups: CH, NC, NCþ 100 ng/ml IGF-1 (PEPROTHECH
Asia, 100-11, USA), CH þ 1 mM 7-[trans-3-[(azetidin-1-yl)methyl]-
cyclobutyl]-5-(3-benzyloxyphenyl)-7H-pyrrolo[2,3-d]pyrimidin-
4-amine (NVP-AEW541) (CAYMAN, S1034, USA). The initial cell
amount of each group was 1.6  105. IGF-1 or NVP-AEW541 wasTable I
CH chondrocytes samples used for analysis
Case Gender Age (years) Affected side SPECT
1 m 23 Right þ
2 f 16 Right þ
3 f 18 Left þ
4 f 18 Left þ
5 m 17 Right þ
6 f 20 Right þadded in the medium at day 5, 12 and 19, and cellular quantity was
counted 2 days after the treatment17,18. Thereafter, beads were
washed three times with Phosphate Buffered Saline (PBS) and
dissolved by adding (40 ml/alginate bead) solution buffer (0.055 M
sodium citrate, 0.03 M ethylenediamine tetra acetic acid, 0.15
sodium chloride diluted in H2O, pH 6.8), followed by vortexing19.
Cells were separated from alginate beads by centrifugation (900 g,
3 min), then resuspended and counted by the Cell Viability
Analyzer, Vi-cell 1.01(Beckman Coulter, USA). Cellular viability was
monitored by trypan blue staining.
To determinemolecular pathways involved in IGF-1-induced CH
chondrocytes proliferation, encapsulated beads were randomly
divided into the following three groups: CH, CH þ 10 mM U0126
(CST, 9903S, USA), CH þ 15 mM LY294002 (CST, 9901S, USA).
Addition of inhibitor U0126 or LY294002 was carried out on day 5,
12 and 19, and the beads were incubated for 1 h before medium
changed, then changed with culture medium17. Cellular quantity
was counted 2 days after the treatment.
Primary cells cultured in monolayers were transferred in 96-well
plates at 500 cells/well, and assessed by 3-(4,5-dimethylthiazo(-2-yl)-
2,5-diphenyltetrazolium bromide (MTT) assays as previous
described20.
Enzyme-linked immunosorbent assay (ELISA) for IGF-1
Culture supernatants of alginate beads were collected from
threewells of NC, CH and CHþNVP-AEW541 group at day 7,14, and
21. Monolayer culture supernatants were also collected at 24 h,
48 h, and 72 h. IGF-1 concentrations were measured by ELISA using
the commercial Human IGF-1 Quantikine Kit (R&D Systems,
dg100), according to the manufacturers’ protocol. Absorbance was
measured at 450 nm using a microplate reader (Nanodrop,
Thermo). The parameters were normalized by the cellular quantity.
RNA extraction and real-time polymerase chain reaction
(real-time PCR)
Chondrocytes in alginate beads culture were incubated with or
without IGF-1 and U0126 for 12 h at day 14 and 21. Next, cellular
pellets were harvested after dissolving alginate beads. Total RNA
were extracted from cells using trizol (TAKARA, D9108A) and
450 ng total RNA were reverse transcribed in cDNA using oligo
(dT)15 as a reverse primer according to the manufacturer’s protocol
(TAKARA, DRR037A). Equivalent amounts of cDNA were used for
real-time PCR in a 20ul reaction mixture with 10ul of 2 SYBR
Green PCR Mastermix and 1 ml of speciﬁc primer pair. Reaction was
run in triplicate with 40 cycles of ampliﬁcation on an ABI Prism
7500 real-time PCR (Applied Biosystems, USA). The sequences of
primers were shown in Table III. The expression levels of target
genes were normalized by the expression of 18S gene measured in
parallel samples.
Western blot analysis for IGF-1R
Atday21, six beads fromeach sampleweredissolved and cellular
lysiswas collected. Lysis supernatant containing 50 mgproteins from
each sample was collected as we previously described21. Samples
Table III
Description of the designed primers
mRNA template Primer sequence
IGF-1 Sense 50-TCTTCAGTTCGTGTGTGGAGACAG-3’
Antisense 50-GGGTGCGCAATACATCTCCAG-3’
IGF-1R Sense 50-CTGAAAGGAAGCGGAGAGATG-30
Antisense 50-GCAAAGACGAAGTTGGAGGC-30
Cyclin D1 Sense 50-GGAGTGTGGTGGCCGCGATG-30
Antisense 50-CGGAGGCAGTCCGGGTCACA-30
CDK2 Sense 50-TCTCACCgTgTCCTgCACCgA-3’
Antisense 50-GGCCCTGCGGGTCACCATTTC-3’
G2/mitotic-speciﬁc
cyclin B1
Sense 50-ATTCTGGATAATGGTGAATGGACAC-3’
Antisense 50-GTCATGTGCTTTGTAAGTCCTTGAT
M-phase inducer
phosphatase
Sense 50-CGGAGCAGACGTTTGAACAGG-3’
Antisense 50-CTGGGAGTTGGTGATGTTCCG-3’
PCNA Sense 50-GGCCGAAGATAACGCGGATAC-3’
Antisense 50-GGCATATACGTGCAAATTCACCAG-3’
COL10A1 Sense 50-CAAGGCACCATCTCCAGGAAC-3’
Antisense 50-GGTATTTGTGGCAGCATATTCTCAG-3’
COL2A1 Sense 50-CCAGTTGGGAGTAATGCAAGGA-3’
Antisense 50-ACACCAGGTTCACCAGGTTCA-3’
18S Sense 50-GGTAgTGACgAAAAATAACAATACAGGAC-3’
Antisense 50-ATACGCTATTGGAGCTGGAATTACC-3’
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acrylamide gels, and were transferred to polyvinylidene diﬂuoride
membranes. After the membrane was blocked in 5% non-fat milk,
the membrane was incubated overnight with the primary antibody
speciﬁc to IGF-1R (Biolegend, 351803,USA) and washed three times
with Tris-buffer saline containing 0.05% Tween 20 (TBST), followed
by incubation with horseradish peroxidase-labeled secondary
antibody for 1 h. The membranes were washed, and speciﬁc bands
were visualized on X-ray ﬁlms using enhanced chemiluminescence
kit (Roche,Germany). The grayvalue of bands of IGF-1Rwere readby
the In-vivo multispectral imaging system (KODAK, USA) and
normalized by that of GAPDH.
Statistics analysis
Statistical analyses were done with the SPSS 18 statistical soft-
ware program. Data are expressed as mean  95% conﬁdence
interval (95% CI), and were considered statistically signiﬁcant for
P < 0.05. Gaussian distribution and homogeneous variance were
tested in all original data. For comparisons among normally
distributed data, two-sample t-test and one-way analyses of vari-
ance (ANOVA) followed by pairwise multiple comparisons were
used, when a signiﬁcant F-ratio was found, signiﬁcant differences
among treatment groups were identiﬁed by the post hoc Scheffé
test. For non-normally distributed data, ManneWhitney non-
parametric analyses and non-parametric KruskaleWallis test fol-
lowed by pairwise multiple comparisons were used.
Results
CH chondrocytes possess higher proliferation capacity
than NC chondrocytes
The morphology of primary CH chondrocytes cultured in
monolayer was round or polygonal [Fig. 1(A,B)], while NC chon-
drocytes displayed a homogeneous small ﬁbroblast-like appear-
ance [Fig. 1(C, D)]. Chondrocytes proliferation capacity was
compared between NC and CH group when cells were cultured in
alginate beads within 21 days. As illustrated in Fig.1(E), cell amount
in CH group was signiﬁcantly higher than that in NC group at each
time point (day 7, P ¼ 0.042; day 14, P ¼ 0.036; day 21, P ¼ 0.002),
although a continuous increase of cellular quantity from day 7 was
presented in these two groups. To exclude the potential effects ofthree-dimensional culture on cellular proliferation, cells cultured in
monolayer were also investigated by MTT assay. As shown in
Fig. 1(F), the cellular quantity in CH group chondrocytes was higher
at day 5 and 7 (day 5, P ¼ 0.002; day 7, P ¼ 0.001).
Enriched expressions of IGF-1 and IGF-1R in CH chondrocytes
A time course study was performed to compare IGF-1 protein
production in alginate beads culture between CH and NC group. The
levels of IGF-1 concentration in CH group were signiﬁcantly higher
than those in NC group from day 7 to day 21 [P < 0.0001 Fig. 2(A)].
At day 7, an average IGF-1 concentration over than 281.1 pg/ml
(95% CI ¼ 238.3e323.89, N ¼ 3) was detected in CH cells.
Thereafter, a peak level occurred at day 14. On the contrary, the
level of IGF-1 concentration in NC group (mean ¼ 57.6 pg/ml, 95%
CI ¼ 44.75e70.56, N ¼ 3) was relatively constant during the whole
observing period. Addition of NVP-AEW541, a speciﬁc inhibitor
against IGF-1R, signiﬁcantly suppressed the level of IGF-1 concen-
tration of CH chondrocytes at day 7 (P< 0.0001), day 14 (P¼ 0.002)
and day 21 (P ¼ 0.01) [Fig. 2(B)]. Again, our monolayer culture
experiment demonstrated that the level of IGF-1 expression in CH
chondrocytes was also signiﬁcantly higher than that in NC cells at
day 21 [P < 0.0001, Fig. 2(C)].
Subsequently, we perform real-time PCR to compare gene
expression alterations of IGF-1 and IGF-1R from between CH and
NC chondrocytes. Compared with NC cells, signiﬁcantly higher
expression levels of IGF-1 (w52-fold at day 14, P ¼ 0.007; w5.8-
foldat day 21, P ¼ 0.035) and IGF-1R genes (P ¼ 0.022) were pre-
sented in CH cells (Fig. 3). Likewise, the expression level of IGF-1R
protein from CH cells detected by western blotting at day 21 was as
about 1.57-fold higher as that of NC cells (P ¼ 0.037) (Fig. 4).
IGF-1 enhanced CH chondrocyte proliferation
We next examined the effect of IGF-1 on chondrocytes prolif-
eration by addition of IGF-1 or NVP-AEW541 (Fig. 5). The data
showed that proliferation capacity of CH chondrocytes signiﬁcantly
declined with the supplement of NVP-AEW541 at day 14
(P ¼ 0.002) and day 21 (P < 0.0001), while NC cells proliferated
rapidly with the exposure of IGF-1 at day 14 (P ¼ 0.005) and day 21
(P < 0.0001). Cellular viability of CH chondrocytes was more than
90% after the treatment.
Furthermore, speciﬁc genes associatedwith cellular proliferation
control and cell cyclingwas investigated by real-time PCR. As shown
in Fig. 6(A), treatment of NVP-AEW541 signiﬁcantly suppressed
proliferating cell nuclear antigen (PCNA) (P ¼ 0.002), G2/mitotic-
speciﬁc cyclin B1 (P ¼ 0.046) and M-phase inducer phosphatase
(P ¼ 0.002) gene expressions. On the other hand, IGF-1 signiﬁcantly
enhanced gene expressions of PCNA (P¼ 0.049), but itwasdifference
in gene expressions of G2/mitotic-speciﬁc cyclin B1 (P ¼ 0.05) and
M-phase inducer phosphatase (P ¼ 0.084) in NC chondrocytes.
CH chondrocytes retain higher matrix synthesis activity
than NC chondrocytes
To compare matrix synthesis activity of chondrocytes between
NC and CH group, we investigated gene expressions of collagen
type II A1 (COL2A1) and collagen type X A1 (COL10A1) from cells
cultured in alginate beads within 21 days of both groups. As shown
in Fig. 6(D), gene expression levels of COL2A1 was 4.63-fold higher
in CH cells than those in NC cells (P ¼ 0.018), while there was no
signiﬁcant difference for COL10A1 between these two groups
(P ¼ 0.531). Besides, treatment of IGF-1 signiﬁcantly enhanced
COL2A1 expression (P ¼ 0.027) in NC chondrocytes. When treated
with NVP-AEW541, CH chondrocytes did not exhibit signiﬁcant
Fig. 1. The morphology of primary chondrocytes is shown by phase-contrast micrographs (magniﬁcation: 10). (A) CH, day 5 (B), CH, day 12 (C) NC, day 5 (D) CH, day 12 are shown.
Scale bar ¼ 100 mm. Comparison of proliferation of chondrocytes cultured in alginate beads (E) and cultured in monolayer by MTT assay (F). Comparisons of cell amount or mean
optical density (OD) value in chondrocytes of CH and NC groups were statistics analyzed by two-sample t-test. Data represent the mean  95% CI and the results shown represent
three independent experiments. N ¼ 3. (E) Cell amount in CH group was signiﬁcantly higher than that in NC group at each time (*represents day 7, P ¼ 0.042; day 14, P ¼ 0.036; day
21, P ¼ 0.002); (F) The cellular quantity in CH group chondrocytes was higher at day 5 and 7 (*represents day 5, P ¼ 0.002; day 7, P ¼ 0.001).
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(P ¼ 0.998) genes [Fig. 6(E, F)].
IGF-1-induced CH chondrocytes proliferation is mediated through
the mitogen-activated protein kinase (MAPK)eERK pathway
We further explored the signaling pathways involved in IGF-
1-induced CH chondrocytes proliferation. The addition of U0126,
a speciﬁc inhibitor of MAPKeERK pathway, at each time pointsuppressed the proliferation capacity of CH chondrocytes (Fig. 7,
P¼ 0.029).Whereas, the treatment of LY294002, a speciﬁc inhibitor
of phosphatidy1 inositol-3 kinase (PI3K) pathway, exhibited no
effects on the capacity of CH cells proliferation during the observing
period (Fig. 7, P ¼ 0.45). Taken together, these data indicated that
IGF-1-stimulated CH chondrocytes proliferation depends on
MAPKeERK pathway.
In addition, speciﬁc genes of MAPKeERK pathway downstream
molecules, which regulate cell-cycle to start the cellular
Fig. 2. The comparisons of the expression of IGF-1 protein by ELISA assay. The data are the mean  95% CI of the three independent experiments and normalized by cell quantity of
105 cells. With the same initial cell amount of beads per well, supernatant of culture medium from randomwell for 48 h was collected at day 7, 14 and 21. (A) Comparisons of levels
of IGF-1 concentration between CH and NC group in alginate culture were statistics analyzed by two-sample t-test. N ¼ 3 (*represents P < 0.0001); (B) Comparisons between CH and
CH þ NVP-AEW541 groups in alginate culture were statistics analyzed by two-sample t-test. N ¼ 3 (day 7, *represents P < 0.0001; day 14, *represents P ¼ 0.002 and day 21,
*represents P ¼ 0.01). (C) Comparisons of levels of IGF-1 concentration in CH, NC and control group in monolayer culture were statistics analyzed by ANOVA. N ¼ 3 (*represents
P < 0.0001). There was no signiﬁcant difference between the two groups at 24 h and 48 h except for 72 h. At 72 h, the mean concentration of CH group and NC group was 463 pg/ml
(95% CI ¼ 281.4e644.6, N ¼ 3) and 10 pg/ml (95% CI ¼ 0e23.3, N ¼ 3), respectively. The fresh culture medium was chosen as a control group and IGF-1 could be hardly detected at
each time point.
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Fig. 8, there were higher gene expression levels in CH cells than in
NC cells for Cyclin D1 (P ¼ 0.002) and cyclin-dependent kinase2
(CDK2) (P ¼ 0.001), while there was a marked decline in CH cells
under the incubation of U0126 for Cyclin D1 (P ¼ 0.03) and CDK2
(P ¼ 0.042).
Discussion
In the former studies, chondrocytes were proved to have
a tendency to dedifferentiate if they grew in monolayer culture15.
We also found the round CH chondrocytes rapidly transformed into
ﬂattened ﬁbroblast-like cells in the monolayer culture, and lost
their high proliferation capacity as the same as NC chondrocytes
did at passage 2 (data not shown). The classic experiments on
chondrocyte culture suggested three-dimensional culture offers
a scaffolding material maintaining the original chondrocyte
phenotype as it facilitates chondrocytes aggregate and mimic vivo
environment15. Therefore, alginate beads culture was preferred inFig. 3. Real-time PCR analysis for genes of IGF-1 and IGF-1R. Total RNA obtained from cho
pendently performed in triplicate. 18S was chosen as the endogenous gene. Gene expressi
bottom, and fold increase is indicated in the Y-axis. The bar represent mean  95% CI, resul
mRNA expressions alterations from between CH and NC chondrocytes were statistics analyze
was 52efold (32, 73) higher than that of NC group (*represents P ¼ 0.007, N ¼ 3). However
expression in CH cells is 256-fold（11, 501）to that of NC cells at day 21 (*represents P ¼ 0the present study as such method avoids passage culture and
enables cells continue to proliferate, maintain their phenotypes22.
In this study, amount of IGF-1 protein in CH showed a peak at day 7,
decreased at day 21 in alginate culture, meanwhile constantly
increased in monolayer culture. This is due to the different culture
condition.
The initial stage of condylar growth and remolding undergoes
chondrogenesis, which results from the chondrocytes proliferation.
Our results showed that CH chondrocytes possess higher prolifer-
ation capacity than NC chondrocytes, which is in agreement with
the histopathological results that the actively growing type of CH
condyles was characterized by a broad proliferation zone or
mesenchyme layer2,23. Our previous study from immunohisto-
chemistry analysis had found that the expressions of IGF-1 were
strong in the active CH condyle and presented mainly in the
proliferative chondrocyte layer12. In this study, ELISA and western
blotting results demonstrated that CH chondrocytes signiﬁcantly
increased IGF-1 and IGF-1R protein production levels than NC
chondrocytes. Moreover, gene expressions of IGF-1 and IGF-1Rndrocytes of six beads. Each group contained 3 samples and each sample was inde-
on was quantiﬁed relatively using the 266CT method. Each group is indicated at the
ts shown represent three independent experiments. Comparisons of IGF-1 and IGF-1R
d by two-sample t-test. (A) The mean relative expression of IGF-1 in CH group at day 14
, it was lower to 5.7-fold（1.5, 9.6） at day 21 (*represents P ¼ 0.035); (B) IGF-1R gene
.022, N ¼ 3).
Fig. 4. IGF-1R protein expression at CH and NC chondrocytes. GAPDH was used as a control. The bar represents mean  95% CI, results shown represent three independent
experiments. Comparisons of IGF-1R protein expressions from between CH and NC chondrocytes were statistics analyzed by ManneWhitney non-parametric test. The mean relative
gray value of IGF-1R of CH group was 1.574-fold (1.35, 1.797) to that of NC group (*represents P ¼ 0.037, N ¼ 3).
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in many tissues during their postnatal development through
promoting mitogenesis, cell migration, survival and protein
synthesis by endocrine and autocrine mechanisms18,24. However,
aberrant IGF-1 expression or signaling would cause various human
diseases, such as certain growth disorder or cancer. In human
melanoma, Molhoek suggested that IGF-1 is a growth factor for
autocrine driven proliferation in vitro25. Melanoma cells elevated
IGF-1 synthesis. In turn, IGF-1 enhanced proliferation of melanoma
cell26. Other investigators had proven that IGF-1 also promotes the
proliferative activity of colon cancer cells27, breast cancer cells28,
and tendon cell29. Accordingly, it is reasonable for us to examine
the effect of IGF-1 on CH chondrocytes proliferation by addition of
IGF-1 or NVP-AEW541, which is a speciﬁc inhibitor against IGF-1R.Fig. 5. Effects of IGF-1 and NVP-AEW541 on CH and NC chondrocytes proliferation.
Encapsulated beads were categorized and treated as described in Materials and
methods. The bar represents mean  95% CI, results shown represent three inde-
pendent experiments. Comparison of cell amount in CH and NC groups were statistics
analyzed by ANOVA (N ¼ 3). The initial cellular density was 1.66  105 cells/2 beads/
well in each group. At day 7, visible cell amount in CH group was signiﬁcantly higher
than that of other three groups (*represents P ¼ 0.024). The data showed that prolif-
eration capacity of CH chondrocytes markedly declined with the supplement of NVP-
AEW541 at day 14 (*represents P ¼ 0.002) and day 21 (*represents P < 0.0001), while
NC cells proliferated rapidly with the exposure of IGF-1 at day 14 (#represents
P ¼ 0.005) and day 21 (#represents P < 0.0001).The proliferation capacity of CH chondrocytes was signiﬁcantly
declined by the supplement of NVP-AEW541, while NC cells
proliferated rapidly with the exposure of IGF-1. Furthermore,
treatment of NVP-AEW541 signiﬁcantly suppressed the expression
levels of speciﬁc genes associated with cellular proliferation control
and cell cycling. Thus, these ﬁndings demonstrated that the
enriched IGF-1 in CH cartilage enhanced CH chondrocytes prolif-
eration. Besides, using NVP-AEW541, we demonstrated that IGF-1
induced its own synthesis in chondrocytes. The elevated IGF-1 in
CH cartilage is the production of local chondrocytes suggesting that
the secreted IGF-1 from CH chondrocytes is utilized by themselves
to enhanced chondrocytes proliferation. Subsequently, increased
chondrocytes in CH cartilage continue to produce IGF-1, which
keeps an aberrant high concentration level in local cartilage. This
positive feedback loop indicated that IGF-1 is a potent growth
factor in the CH pathological development process. Collectively, the
abnormality of cartilage growth in CH is attributed to IGF-1 over-
expression for autocrine driven proliferation.
Another important factor in the cartilage growth pattern is
matrix synthesis30. Our ﬁndings showed that an enhanced gene
expression level of COL2A1 in CH chondrocytes, and IGF-1
promoted the expression of COL2A1 in chondrocytes, suggesting
IGF-1 participates in the CH pathological development partially
through augmenting matrix synthesis capacity of chondrocytes.
When treated with NVP-AEW541, CH chondrocytes did not
remarkably alter the expression levels of COL2A1, indicating that
IGF-1 may not be the only critical factor affecting the matrix
synthesis of CH chondrocytes. Cellular hypertrophy is an important
factor for cartilage interstitial growth31. Collagen Type X is known
to be a marker for hypertrophic chondrocytes32. In the present
study, CH chondrocytes exhibited a low expression of COL10A1
gene and no signiﬁcant alteration of such gene expression in
chondrocytes when treated with IGF-1 or NVP-AEW541, which
suggested that IGF-1 would not mediate chondrocytes toward
hypertrophic differentiation in the process of CH development.
Some studies have shown that IGF-1modulates the proliferation
of somatic cells, such as tendon cells and costal chondrocytes, by
activating two major intracellular signaling pathways, MAPK and
PI3K pathway33,34. It is notable that different cell types comprise
the speciﬁc signaling pathways involved in IGF-1-induced prolif-
eration. For example, MAPK pathway is exclusively involved in the
IGF-1-induced cellular proliferation of myoblasts and adipocytes,
while stimulation of MCF-7 mammary tumors and brain capillary
Fig. 6. Real-time PCR analysis of PCNA (A), G2/mitotic-speciﬁc cyclin B1 (B), M-phase inducer phosphatase expressions (C), COL2A1 and COL10A1 (D, E and F). At day 21, 100 ng/ml
IGF-1 and 10 mM NVP-AEW541 was added into the fresh medium of three wells and incubated for 6 h. Thereafter, RNA was extracted from cells harvested after dissolving alginate
beads and mRNA was assessed. The bar represent mean and 95% CI, results shown represent three independent experiments. Gene expression was normalized to 18S. Comparisons
of PCNA, COL2A1 and COL10A1 gene expressions were statistics analyzed by ANOVA, and the data of G2/mitotic-speciﬁc cyclin B1 and M-phase inducer phosphatase genes
expressions were ﬁrst statistics analyzed by KruskaleWallis test (P ¼ 0.041 and P ¼ 0.024 respectively, N ¼ 3) and the following multiple comparisons were statistics analyzed by
ANOVA. (A) #represents P ¼ 0.002, CH vs CH þ NVP-AEW541, *represents P ¼ 0.049, NC vs NC þ IGF-1, N ¼ 3; (B) #represents P ¼ 0.046, CH vs CH þ NVP-AEW541, *represents
P ¼ 0.05, NC vs NC þ IGF-1, N ¼ 3; (C) #represents P ¼ 0.002, CH vs CH þ NVP-AEW541, *represents P ¼ 0.084, NC vs NC þ IGF-1, N ¼ 3; (D) *represents P ¼ 0.018, CH vs NC, N ¼ 3;
(E) #represents P ¼ 0.027, NC vs NC þ IGF-1, N ¼ 3; (F) There are no signiﬁcant difference among all the groups.
Y. Chen et al. / Osteoarthritis and Cartilage 20 (2012) 279e287 285cellular proliferation by IGF-1 is mediated via PI3K pathway. In
addition, in mammary epithelial cells, IGF-1 induce cellular
proliferation via both two pathways35. To determine pathways
responding to IGF-1-induced CH chondrocytes proliferation, we
used two speciﬁc pharmacological inhibitors, U0126 and LY294002.
As a result, U0126 but not LY294002, signiﬁcantly inhibited cellularFig. 7. Effects of speciﬁc MAPKeERK inhibitor U0126 or PI3-K inhibitor LY294002 on
the CH chondrocytes proliferation. The bar represent mean and 95% CI, results shown
represent three independent experiments. At each time point, mean cell viability of
each sample was calculated from that of three wells, and the initial cell mount per well
was 1.66  105 cells. Comparison of cell amount in all groups was statistics analyzed by
ANOVA. Visible cell amount in CH chondrocytes treated with U0126 was signiﬁcantly
declined than that in untreated CH cells (#represents at day 7, P ¼ 0.014; at day 14,
P ¼ 0.002; at day 21, P ¼ 0.003, N ¼ 3). On the contrary, there was no difference
between CH and CH cells treated with LY294002 group (*represents at day 7, P ¼ 0.161;
at day 14, P ¼ 0.529; at day 21, P ¼ 0.113, N ¼ 3).proliferation indicating MAPKeERK pathway is mainly responsible
for IGF-1 induced CH chondrocytes proliferation. IGF-1 induces the
sequential activation of MAPK, which then activates ‘classical’
MAPK family members like extracellular-signal-regulated kinase
1/2 (ERK1/2), ERK536,37. Activated ERK1/2 phosphorylates tran-
scription factors and protein kinases, thereby transmitting extra-
cellular signals to the nucleus and inducing immediate early genes
associated with cell-cycle. It is widely accepted that chondrocytes
proliferation is initiated by cell-cycle entry, which is mainly
promoted by transcription factors and protein kinases, such as
Cyclin D1 and CDK2. The present study demonstrated that such two
gene expression levels in CH cells were signiﬁcantly higher than
those in NC cells, which suggests that increased cell-cycle entry
signals transmit in CH cell nucleus to start cellular proliferation.
Besides, when ERK1/2 was blocked by U0126, Cyclin D1 and CDK2
messenger RNA (mRNA) down-regulated to similar levels of those
in NC cells, which indicated that MAPKeERK pathway plays
important roles to mediate such signals transmitting from extra-
cellular into CH cellular nucleus.
Interestingly, even in the long-term culture, CH chondrocytes
proliferation started to stagnated since from the fourth week. By
telomeric repeat ampliﬁcation protocol assay, we found no
detectable telomerase activity in CH chondrocytes (data not
shown), which suggested CH chondrocyte is not a kind of immor-
talized cell38. Furthermore, silver staining combined light micro-
scopic examination experiment showed no cytologic and nuclear
atypia in CH chondrocytes and no difference in mitotic counts
between CH and NC cells (data not shown). These ﬁndings implied
that CH chondrocyte is not a kind of immortalized or tumor-like
cell. To further clarify the characteristics of CH chondrocyte is
a major objective in our ongoing study.
In conclusion, IGF-1 promotes human TMJ cartilage overgrowth
in the CH developing process by enhancing chondrocytes prolifer-
ation via MAPKeERK pathway. These results will be helpful to
Fig. 8. Real-time PCR analysis of cell-cycle regulator genes in CH chondrocyte. Total RNA randomly obtained from chondrocytes of six beads. Each group contained three samples.
18S was chosen as the endogenous gene. Gene expressionwas quantiﬁed relatively using the 266CT method. Each group is indicated at the bottom, and fold increase is indicated in
the Y-axis. The bar represents means  SD of three independent experiments, N ¼ 3. Comparisons of gene expressions were statistics analyzed by ANOVA. At day 21, culture medium
was changed and 2 mM U0126 was added into the fresh medium and cells were incubated for 6 h. there were higher gene expression levels in CH cells than in NC cells for Cyclin D1
(P ¼ 0.002) and CDK2 (P ¼ 0.001), while there was a marked decline in CH cells under the incubation of U0126 for Cyclin D1 (A: *represents P ¼ 0.03) and CDK2 (B: *represents
P ¼ 0.042).
Y. Chen et al. / Osteoarthritis and Cartilage 20 (2012) 279e287286explore a novel therapeutic method for CH in its actively growing
stage.
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